Drawing for K2DELTA

USPTO serial 86703565

K2DELTA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FLOWERS, JAY K
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with K2DELTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Felicia G. Traub

FELICIA G TRAUB CULHANE MEADOWS PLLC100 Crescent Court, Suite 700Dallas, TX 75201UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations for the treatment of skin disease, inflammatory diseases and disorders, immunology diseases and disorders, infectious diseases and disorders, diabetes, hypertension and depression, muscoskeletal diseases and disorders, cardiological and vascular diseases and disorders, pulmonary and respiratory diseases and disorders, endocrine diseases and disorders, gastroneterological diseases and disorders, hematological diseases and disorders, osteoporosis, nephrological and urological diseases, neurological diseases and disorders, ophthalmological diseases and disorders, otolaryngological diseases and disorders, rheumatological diseases and disorders; antibacterial pharmaceuticals; vitamin enriched milk and milk products, namely, milk, skimmed milk, cultured and fermented milk, dried milk powder, condensed milk, grain milk, plant milk, butter and butter-containing fats for cooking and spreading, yoghurt, quark, cream, cheeses all for medical purposes; Dietetic sugars enriched with vitamins, namely, preparations used for sweetening, namely, saccharose, sucrose, glucose, dextrose, fructose, galactose, lactose, maltose, xylitol all for medical purposes; other sweetening carbohydrates and sugar alcohols namely, brazzein, curculin, erythritol, fructooligosaccharide, glycyrrhizin, glycerol, inulin, lacticol, mogrocide, mabinlin, maltilol, mannitol, miraculin, monatin, mnellin, osladin, pentadin, polydextrose, sorbitol, stevia, tagatose and thaumatin; artificial sweeteners, namely, aspartame, advantame, alitame, cyclamate, duclin, glucin neotame, saccharin, and sucralose, all enriched with vitamins; dietary supplements for humans and animals; food for babies enriched with vitamins; veterinary preparations, namely, animal feed supplements enriched with vitamins; dietary vitamins supplements for non-medical use; Dietary vitamin supplements combined with minerals or amino-acids for non-medical use; dietary vitamin supplements in the form of granulates, powders, emulsions, tablets, capsules, syrup, liquids, sweets; dietary vitamin supplements in the form of preparations based on milk and milk products, edible oils and fats, cereals, fruits, vegetables; dietary supplements for humans containing vitamins in the form of energy bars, pastes, drinks, shakes, yoghurts, juices, gels, powders ready-to mixACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 2, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 25, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 25, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 21, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 27, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 27, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 7, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 21, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 21, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Nov 21, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 21, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 21, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 11, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 11, 2016ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 11, 2016EXPIEX PARTE APPEAL-INSTITUTED—
Nov 11, 2016JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Nov 11, 2016EXAFEXPARTE APPEAL RECEIVED AT TTAB—
May 12, 2016GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 12, 2016GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 12, 2016CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 3, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 2, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 2, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 22, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 22, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 20, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 5, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2015DOCKASSIGNED TO EXAMINER—
Jul 31, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Jul 30, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 28, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance